Jae Woong Jang, Aaron Abrams, Anugayathri Jawahar, Hatice Savas, Ximing J Yang, Vikas Mehta, Marina Schnauss, Edward M Schaeffer, Ridwan Alam, Ashley E Ross
{"title":"考虑局灶治疗的患者使用PSMA PET/CT检测mri不可见疾病","authors":"Jae Woong Jang, Aaron Abrams, Anugayathri Jawahar, Hatice Savas, Ximing J Yang, Vikas Mehta, Marina Schnauss, Edward M Schaeffer, Ridwan Alam, Ashley E Ross","doi":"10.1155/criu/2981515","DOIUrl":null,"url":null,"abstract":"<p><p>Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion-harboring cancer detected only on PSMA PET/CT. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT05852041.</p>","PeriodicalId":30323,"journal":{"name":"Case Reports in Urology","volume":"2025 ","pages":"2981515"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964713/pdf/","citationCount":"0","resultStr":"{\"title\":\"Detection of MRI-Invisible Disease Using PSMA PET/CT in a Patient Considering Focal Therapy.\",\"authors\":\"Jae Woong Jang, Aaron Abrams, Anugayathri Jawahar, Hatice Savas, Ximing J Yang, Vikas Mehta, Marina Schnauss, Edward M Schaeffer, Ridwan Alam, Ashley E Ross\",\"doi\":\"10.1155/criu/2981515\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion-harboring cancer detected only on PSMA PET/CT. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT05852041.</p>\",\"PeriodicalId\":30323,\"journal\":{\"name\":\"Case Reports in Urology\",\"volume\":\"2025 \",\"pages\":\"2981515\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964713/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/criu/2981515\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/criu/2981515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Detection of MRI-Invisible Disease Using PSMA PET/CT in a Patient Considering Focal Therapy.
Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion-harboring cancer detected only on PSMA PET/CT. Trial Registration: ClinicalTrials.gov identifier: NCT05852041.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
